Harmon Cyrus sold OLMA
September 18, 2025 · Form 4 insider transaction
Harmon Cyrus sold 3,086 shares of Olema Pharmaceuticals, Inc. at $8.32 per share, a transaction worth $25.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,086
Price
$8.32
Total value
$25.7K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 18, 2025
Filing dateSeptember 18, 2025
Shares owned after117,028
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $8.32, and the range of prices was between $8.29 and $8.33. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.; The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.